MX2015008029A - Heterociclos n-acetilados y de nitrogeno saturados que potencian la actividad de un antibiotico activo contra micobacterias. - Google Patents
Heterociclos n-acetilados y de nitrogeno saturados que potencian la actividad de un antibiotico activo contra micobacterias.Info
- Publication number
- MX2015008029A MX2015008029A MX2015008029A MX2015008029A MX2015008029A MX 2015008029 A MX2015008029 A MX 2015008029A MX 2015008029 A MX2015008029 A MX 2015008029A MX 2015008029 A MX2015008029 A MX 2015008029A MX 2015008029 A MX2015008029 A MX 2015008029A
- Authority
- MX
- Mexico
- Prior art keywords
- activity
- potentiating
- saturated nitrogen
- heterocycles
- antibiotic against
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title abstract 3
- 230000000694 effects Effects 0.000 title abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 title abstract 2
- 230000003389 potentiating effect Effects 0.000 title abstract 2
- 150000002829 nitrogen Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 241000894006 Bacteria Species 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 206010062207 Mycobacterial infection Diseases 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 208000027531 mycobacterial infectious disease Diseases 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1203548A FR3000065A1 (fr) | 2012-12-21 | 2012-12-21 | Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes |
| PCT/EP2013/077732 WO2014096378A1 (fr) | 2012-12-21 | 2013-12-20 | Hétérocycles azotés saturés et n-acylés potentialisant l'activité d'un antibiotique actif contre les mycobactéries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015008029A true MX2015008029A (es) | 2015-10-30 |
Family
ID=48521019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015008029A MX2015008029A (es) | 2012-12-21 | 2013-12-20 | Heterociclos n-acetilados y de nitrogeno saturados que potencian la actividad de un antibiotico activo contra micobacterias. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9957249B2 (enExample) |
| EP (1) | EP2935212B1 (enExample) |
| JP (1) | JP6515035B2 (enExample) |
| KR (1) | KR20150138152A (enExample) |
| CN (1) | CN104955804B (enExample) |
| AU (1) | AU2013366503B2 (enExample) |
| BR (1) | BR112015014279A2 (enExample) |
| CA (1) | CA2895606A1 (enExample) |
| CL (1) | CL2015001640A1 (enExample) |
| CR (1) | CR20150319A (enExample) |
| EA (1) | EA028076B1 (enExample) |
| FR (1) | FR3000065A1 (enExample) |
| GE (1) | GEP20186857B (enExample) |
| IL (1) | IL239504B (enExample) |
| MA (1) | MA38275B1 (enExample) |
| MX (1) | MX2015008029A (enExample) |
| PE (1) | PE20151327A1 (enExample) |
| PH (1) | PH12015501427A1 (enExample) |
| SG (1) | SG11201504492UA (enExample) |
| TN (1) | TN2015000202A1 (enExample) |
| UA (1) | UA117922C2 (enExample) |
| WO (1) | WO2014096378A1 (enExample) |
| ZA (1) | ZA201503719B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA111305C2 (uk) | 2012-12-21 | 2016-04-11 | Пфайзер Інк. | Конденсовані лактами арилу та гетероарилу |
| HRP20210510T1 (hr) | 2012-12-21 | 2021-05-14 | Janssen Biopharma, Inc. | 4'-fluor-nukleozidi, 4'-fluor-nukleotidi i njihovi analozi za liječenje hcv |
| FR3000064A1 (fr) | 2012-12-21 | 2014-06-27 | Univ Lille Ii Droit & Sante | Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes |
| MA40225B1 (fr) | 2014-06-17 | 2019-05-31 | Pfizer | Composés dihydroisoquinolinone substitués |
| CA3072839A1 (en) * | 2017-08-16 | 2019-02-21 | Glaxosmithkline Intellectual Property Development Limited | Compounds for the treatment of mycobacterial infections |
| RU2020110521A (ru) * | 2017-08-16 | 2021-09-17 | Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Новые соединения |
| LT3668879T (lt) * | 2017-08-16 | 2022-03-25 | Glaxosmithkline Intellectual Property Development Limited | Nauji junginiai |
| RU2767542C1 (ru) * | 2021-05-24 | 2022-03-17 | Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" (ПГНИУ) | Противотуберкулезное средство на основе 4-((гет)ароил)-3- гидрокси-1-(2-гидроксифенил)-5-(фенилтио)-1,5-дигидро-2Н-пиррол-2-онов |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4093726A (en) | 1976-12-02 | 1978-06-06 | Abbott Laboratories | N-(2-benzimidazolyl)-piperazines |
| US4547505A (en) * | 1983-03-25 | 1985-10-15 | Degussa Aktiengesellschaft | N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production |
| EP1118612A1 (en) | 2000-01-21 | 2001-07-25 | Universita Degli Studi di Firenze | Piperazine derivatives possesing nootropic activity |
| TW593556B (en) * | 2002-12-27 | 2004-06-21 | Ind Tech Res Inst | Dichroic dye, composition thereof, and liquid crystal composition and liquid-crystal display element containing the same |
| US7601844B2 (en) * | 2006-01-27 | 2009-10-13 | Bristol-Myers Squibb Company | Piperidinyl derivatives as modulators of chemokine receptor activity |
| FR2903405B1 (fr) | 2006-07-04 | 2011-09-09 | Pasteur Institut | Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications |
| TW200938203A (en) * | 2007-12-17 | 2009-09-16 | Intervet Int Bv | Anthelmintic agents and their use |
| EP2234643B1 (en) | 2007-12-21 | 2013-01-09 | ETH Zurich | Composition for treatment of tuberculosis |
| CA2730116A1 (en) * | 2008-07-08 | 2010-01-14 | Boehringer Ingelheim International Gmbh | Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
| CN102256966B (zh) * | 2008-10-17 | 2016-02-10 | 白头生物医学研究所 | 可溶性mTOR复合物和其调节剂 |
| FR2939135B1 (fr) | 2008-12-02 | 2010-12-03 | Galderma Res & Dev | Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
| EP2445495A1 (en) * | 2009-06-25 | 2012-05-02 | Bioversys AG | Composition for treatment of tuberculosis |
| KR101179508B1 (ko) * | 2010-06-24 | 2012-09-07 | 한국과학기술연구원 | 1,6-이치환-3-아미노-4,5,6,7-테트라하이드로-1Ｈ-피라졸로［3,4-ｃ］피리딘-7-온 화합물 및 이 화합물의 제조방법 |
| WO2013060744A2 (en) | 2011-10-25 | 2013-05-02 | Universite De Droit Et De La Sante De Lille 2 | Compounds having an ethr inhibiting activity - use of said compounds as drugs - pharmaceutical composition and product containing said compounds |
| MX2014013752A (es) * | 2012-05-11 | 2014-12-08 | Abbvie Inc | Inhibidores de nampt. |
| NZ702977A (en) | 2012-07-20 | 2017-10-27 | Bayer Pharma AG | 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof |
| FR3000064A1 (fr) | 2012-12-21 | 2014-06-27 | Univ Lille Ii Droit & Sante | Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes |
-
2012
- 2012-12-21 FR FR1203548A patent/FR3000065A1/fr not_active Withdrawn
-
2013
- 2013-12-20 AU AU2013366503A patent/AU2013366503B2/en not_active Ceased
- 2013-12-20 US US14/653,669 patent/US9957249B2/en active Active
- 2013-12-20 MX MX2015008029A patent/MX2015008029A/es unknown
- 2013-12-20 KR KR1020157019623A patent/KR20150138152A/ko not_active Ceased
- 2013-12-20 SG SG11201504492UA patent/SG11201504492UA/en unknown
- 2013-12-20 BR BR112015014279A patent/BR112015014279A2/pt not_active Application Discontinuation
- 2013-12-20 EP EP13814948.9A patent/EP2935212B1/fr active Active
- 2013-12-20 EA EA201590828A patent/EA028076B1/ru not_active IP Right Cessation
- 2013-12-20 PE PE2015001024A patent/PE20151327A1/es unknown
- 2013-12-20 UA UAA201505250A patent/UA117922C2/uk unknown
- 2013-12-20 WO PCT/EP2013/077732 patent/WO2014096378A1/fr not_active Ceased
- 2013-12-20 CA CA2895606A patent/CA2895606A1/fr not_active Abandoned
- 2013-12-20 MA MA38275A patent/MA38275B1/fr unknown
- 2013-12-20 GE GEAP201313844A patent/GEP20186857B/en unknown
- 2013-12-20 JP JP2015548640A patent/JP6515035B2/ja active Active
- 2013-12-20 CN CN201380067137.2A patent/CN104955804B/zh active Active
-
2015
- 2015-05-25 ZA ZA2015/03719A patent/ZA201503719B/en unknown
- 2015-05-25 TN TNP2015000202A patent/TN2015000202A1/fr unknown
- 2015-06-12 CL CL2015001640A patent/CL2015001640A1/es unknown
- 2015-06-17 CR CR20150319A patent/CR20150319A/es unknown
- 2015-06-18 IL IL239504A patent/IL239504B/en not_active IP Right Cessation
- 2015-06-19 PH PH12015501427A patent/PH12015501427A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104955804A (zh) | 2015-09-30 |
| JP2016503778A (ja) | 2016-02-08 |
| HK1215254A1 (zh) | 2016-08-19 |
| US9957249B2 (en) | 2018-05-01 |
| PH12015501427B1 (en) | 2015-09-14 |
| EA028076B1 (ru) | 2017-10-31 |
| AU2013366503B2 (en) | 2018-02-01 |
| CN104955804B (zh) | 2018-02-09 |
| UA117922C2 (uk) | 2018-10-25 |
| CR20150319A (es) | 2015-09-14 |
| KR20150138152A (ko) | 2015-12-09 |
| CA2895606A1 (fr) | 2014-06-26 |
| PE20151327A1 (es) | 2015-10-12 |
| JP6515035B2 (ja) | 2019-05-15 |
| BR112015014279A2 (pt) | 2017-07-11 |
| CL2015001640A1 (es) | 2016-01-29 |
| FR3000065A1 (fr) | 2014-06-27 |
| IL239504B (en) | 2018-10-31 |
| EP2935212A1 (fr) | 2015-10-28 |
| MA38275A1 (fr) | 2017-11-30 |
| MA38275B1 (fr) | 2018-09-28 |
| EP2935212B1 (fr) | 2019-02-27 |
| IL239504A0 (en) | 2015-08-31 |
| GEP20186857B (en) | 2018-06-11 |
| PH12015501427A1 (en) | 2015-09-14 |
| SG11201504492UA (en) | 2015-07-30 |
| US20150307471A1 (en) | 2015-10-29 |
| EA201590828A1 (ru) | 2015-11-30 |
| ZA201503719B (en) | 2016-11-30 |
| TN2015000202A1 (en) | 2016-10-03 |
| WO2014096378A1 (fr) | 2014-06-26 |
| AU2013366503A1 (en) | 2015-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015501427A1 (en) | Saturated nitrogen and n-acylated heterocycles potentiating the activity of an active antibiotic against mycobacteria | |
| MX385731B (es) | Compuestos de biaril-monobactam y métodos de uso de los mismos para el tratamiento de infecciones bacterianas. | |
| GEP20156370B (en) | Fluoro-pyridinone derivatives useful as antibacterial agents | |
| MX2021000189A (es) | Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias. | |
| MX2017016672A (es) | Derivados de 3-tetrazolil-bencen-1,2-disulfonamida como inhibidores de metalo-beta-lactamasa. | |
| BR112015013123A2 (pt) | inibidores de beta-lactamase | |
| UY35834A (es) | Piperazinas de pirazolo sustituido como inhibidores de caseína quinasa 1 delta y epsilon | |
| MX353024B (es) | Compuestos de fenil carbamato para uso en la prevencion o tratamiento de epilepsia. | |
| GEP20186876B (en) | Heterobicycloaryl rorc2 inhibitors and methods of use thereof | |
| PH12019500839A1 (en) | Therapeutic compounds and methods of use thereof | |
| NZ729064A (en) | Heterobicyclic compounds and their use for the treatment of tuberculosis | |
| EP2590978A4 (en) | CARBAPENEM ANTIBACTERIAL AGENTS WITH NEGATIVE ANTI-GRAM ACTIVITY | |
| MX2015005753A (es) | Agentes antimicrobianos. | |
| PH12019500331A1 (en) | Beta-lactamase inhibitors | |
| EA201590876A1 (ru) | Спироизоксазолиновые соединения, обладающие активностью, усиливающей активность антибиотика | |
| GB201117051D0 (en) | Carbonic anhydrase inhibitors | |
| CL2012001758A1 (es) | Uso de compuestos derivados de 8-hidroxiquinolin-7-carboxamida y sus sales, para el tratamiento y/o prevencion de infecciones fungicas. | |
| MX394066B (es) | Nuevos compuestos | |
| ZA201904033B (en) | Pharmaceutical compounds | |
| TH161861A (enExample) | ||
| GEP20186874B (en) | Hydrochloride salts of an antibiotic compound | |
| EA202190617A2 (ru) | Соединения-ингибиторы бета-лактамаз | |
| HK1236202A1 (en) | Beta-lactamase inhibitors | |
| RU2013136121A (ru) | ПРОТИВОТУБЕРКУЛЕЗНОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО: КОМПОЗИЦИЯ ИМИДАЗО[1,2-b]ТЕТРАЗИНА С ПИРАЗИНАМИДОМ | |
| UY30509A1 (es) | Profarmacos antimicrobianos de oxazolidinona |